Price movement over the last 24 hours
AFLAC Incorporated vs ARK Innovation ETF — how do they compare? AFLAC Incorporated trades at $121.41 (market cap $61.84B), while ARK Innovation ETF trades at $80.05. The key difference: AFLAC Incorporated pays a 2.01% dividend while ARK Innovation ETF pays none, and AFLAC Incorporated is trading nearer its 52-week high, ARK Innovation ETF nearer its low. Which is the better fit depends on your goals.
| AFL | ARKK | |
|---|---|---|
Market Cap | $61.84B | — |
Sector | Financials | — |
52-Week High | $121.49 | $92.50 |
52-Week Low | $98.09 | $63.52 |
Enterprise Value | $70.50B | — |
Dividend Yield | 2.01% | — |
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
ARK Innovation ETF (ARKK) trades at $83.61, up 2.9% with a bullish technical outlook from moving averages. The ETF faces mixed sentiment with concerns about its 0.75% expense ratio and 37.88% five-year loss, though recent inflows and AI-focused portfolio shifts show renewed investor interest. Tesla's 10% weighting remains a key driver, while technical indicators show overbought short-term RSI but strong trend momentum.
Outlook hinges on ARKK's concentrated bets in disruptive innovation stocks amid AI momentum, but high fees and volatility pose risks. The ETF's performance remains tied to Tesla and Cathie Wood's stock-picking, with current technical strength suggesting near-term upside if support at $82 holds.
Trailing returns across standard periods
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →